Skip to main content
Laxmi Iyer, MD, Oncology, Riverside, CA

LaxmiIyerMD

Oncology Riverside, CA

Hematologic Oncology

Physician

Dr. Iyer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Iyer's full profile

Already have an account?

  • Office

    4500 Brockton Ave
    Riverside, CA 92501
    Phone+1 951-276-2760

Education & Training

  • University of Maryland
    University of MarylandFellowship, Hematology and Medical Oncology, 2013 - 2016
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 2010 - 2013
  • University of Texas Health Science Center School of Public Health
    University of Texas Health Science Center School of Public HealthMPH, Epidemiology & Disease Control, 2008 - 2010
  • B.J. Medical College - University of Pune
    B.J. Medical College - University of PuneClass of 2006

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2019 - 2025
  • NV State Medical License
    NV State Medical License 2016 - 2021
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Dr. Malati Lagoo Award for Distinction in Obstetrics & Gynecology B. J. Medical College

Publications & Presentations

PubMed

Journal Articles

  • Resected pancreatic ductal adenocarcinomas with recurrence limited in lung have a significantly better prognosis than those with other recurrence patterns  
    Wangjam, T, Zhang, Z, Chong Zhou, X, Iyer, L, Faisal, F, Soares, K, Fishman, E, Hruban, R, Herman, J, Laheru, D, Weiss, M, Li, M, De Jesus-Acosta, A, Wolfgang, C, Zhen..., Oncotarget, 1/1/2015
  • Chemotherapy-induced diarrhea in older patients with colorectal cancer receiving fluoropyrimidines: A retrospective review  
    Iyer, LH, Browner, I, Blackford, AL, Laheru, DA, Azad, N, Diaz, LA, Donehower, RC, Purtell, MJ, Zheng, L, Le, DT, Cosgrove, D, Rasheed, Z, Kadan, M, De Jesus-Acosta, A, J Clin Oncol; GI ASCO, 1/1/2013
  • Molecular targets of nutraceuticals derived from dietary spices: potential role in suppression of inflammation and tumorigenesis  
    Aggarwal, BB, VanKuiken, ME, Iyer, LH, Harikumar, KB, Sung, B, Experimental Biology and Medicine, 1/1/2009

Abstracts/Posters

  • Association of background parenchymal enhancement with breast cancer risk factors and tumor characteristics.
    Iyer, L, Faramand, R, Jung, S, Rosenblatt, P, Campassi, C, Dromi, S, Dorgan, J, Tkaczuk, K, San Antonio Breast Symposium, 1/1/2016
  • Could spironolactone reverse amyotrophic lateral sclerosis?
    Iyer, LH, Abadilla, KA, Greenough, WB, American College of Physicians, Baltimore, MD, 1/1/2012
  • Beta blockers, ACE-I and ARB are related to body weight change, hospitalization rate and survival in patients with non-small cell lung cancer.
    Utech, AE, Wells, D, Iyer, LH, Splenser, A, Boparai, J, Sunseri, C, Tadros, E, Konda, B, Garcia, JM, ENDO, San Diego, CA, 1/1/2010

Other

Press Mentions

  • Potential Advancements in Treatment of PTSD and PTSD-Related Cardiovascular Disease
    Potential Advancements in Treatment of PTSD and PTSD-Related Cardiovascular DiseaseApril 27th, 2021
  • Take the Plunge: Go Beyond Your Sector!
    Take the Plunge: Go Beyond Your Sector!August 9th, 2016

Professional Memberships